- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02864420
Hospitalization at Home: The Acute Care Home Hospital Program for Adults
Hospitalization at Home Pilot: The Acute Care Home Hospital Program for Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hospitals are the standard of care for acute illness in the United States, but hospital care is expensive and often unsafe, especially for older individuals. While admitted, 20% suffer delirium, over 5% contract hospital-acquired infections, and most lose functional status that is never regained. Timely access to inpatient care is poor: many hospital wards are typically over 100% capacity, and emergency department waits can be protracted. Moreover, hospital care is increasingly costly: many internal medicine admissions have a negative margin (i.e., expenditures exceed hospital revenues) and incur patient debt.
The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, 20% reduced cost, and 20% improved patient experience. While this is the standard of care in several developed countries, only 2 non-randomized demonstration projects have been conducted in the United States, each with highly local needs. Taken together, home hospital evidence is promising but falls short due to non-robust experimental design, failure to implement modern medical technology, and poor enlistment of community support.
The home hospital module offers most of the same medical components that are standard of care in an acute care hospital. The typical staff (medical doctor [MD], registered nurse [RN], case manager), diagnostics (blood tests, vital signs, telemetry, x-ray, and ultrasound), intravenous therapy, and oxygen/nebulizer therapy will all be available for home hospital. Optional deployment of food services, home health aide, physical therapist, occupational therapist, and social worker will be tailored to patient need. Home hospital improves upon the components of a typical ward's standard of care in several ways:
- Point of care blood diagnostics (results at the bedside in <5 minutes);
- Minimally invasive continuous vital signs, telemetry, activity tracking, and sleep tracking;
- On-demand 24/7 clinician video visits;
- 4 to 1 patient to MD ratio, compared to typical 16 to 1;
- Ambulatory/portable infusion pumps that can be worn on the hip;
- Optional access to a personal home health aide
Should a matter be emergent (that is, requiring in-person assistance in less than 20 minutes), then 9-1-1 will be called and the patient will be returned to the hospital immediately. In previous iterations of home hospital this happens in about 2% of patients.
Clinical parameters measured will be at the discretion of the physician and nurse, who treat the participant following evidence-based practice guidelines, just as in the usual care setting. In addition, the investigators will be tracking a wide variety of measures of quality and safety, including some measures tailored to each primary diagnosis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02120
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02130
- Brigham and Women's Faulkner Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Resides within 5-mile radius of emergency room
- English- or Spanish-speaker
- Can identify a potential caregiver who agrees to stay with patient for first 24 hours of admission. Caregiver must be competent to call care team if a problem is evident to her/him.
- This criterion may be waived for highly competent patients at the patient and clinician's discretion.
- >=18 years old
- Primary diagnosis of cellulitis, heart failure, complicated urinary tract infection, or pneumonia that requires inpatient admission as determined by blinded emergency room team.
Exclusion Criteria:
- Undomiciled
- No working heat (October-April), no working air conditioning if forecast > 80°F (June-September), or no running water
- On methadone requiring daily pickup of medication
- In police custody
- Resides in facility that provides on-site medical care (e.g., skilled nursing facility)
- Domestic violence screen positive
- Cared for by a private primary care physician who rounds in the hospital
- Cannot establish peripheral access in emergency department (or access requires ultrasound guidance)
- Secondary condition: active non-melanoma/prostate cancer, end-stage renal disease, acute myocardial infarction, acute cerebral vascular accident, acute hemorrhage
- Primary diagnosis requires narcotics for pain control
- Cannot independently ambulate to bedside commode
- As deemed by on-call medical doctor, patient likely to require any of the following procedures: computed tomography, magnetic resonance imaging, endoscopic procedure, blood transfusion, cardiac stress test, or surgery
- For pneumonia:
- Most recent CURB65 > 3: new confusion, blood urea nitrogen > 19mg/dL, respiratory rate>=30/min, systolic blood pressure<90mmHg, Age>=65
- Most recent SMRTCO > 2: systolic blood pressure < 90mmHg (2pts), multilobar chest xray involvement (1pt), respiratory rate >= 30/min, heart rate >= 125, new confusion, oxygen saturation <= 90%
- Absence of clear infiltrate on imaging
- Cavitary lesion on imaging
- O2 saturation < 90% despite 5L O2
- For heart failure:
- Has a left ventricular assist device or paced rhythm
- Get with the Guidelines - Heart Failure (>10% in-hospital mortality) or The Acute Decompensated Heart Failure National Registry score (high risk or intermediate risk 1)
- Anasarca
- Pulmonary hypertension
- For complicated urinary tract infection:
- Absence of pyuria
- Most recent quick sepsis related organ failure assessment > 1
- Home hospital census is full (maximum 4 patients at any time)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Inpatient hospitalization
Control / usual care arm.
Patients are admitted per usual to an inpatient service.
Patients' medical records will be closely monitored.
Patients will wear a vitals and activity monitor whose data is used only retrospectively.
On discharge and 30 days after discharge, they will be interviewed regarding their hospitalization and health.
|
|
Experimental: Home hospitalization
Intervention arm.
Patients will return home after triage, diagnosis, and the beginning of treatment in the emergency department with a set of specialized patient-tailored services (listed above).
On discharge and 30 days after discharge, they will be interviewed regarding their hospitalization and health.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total cost of hospitalization, $
Time Frame: Day of admission to day of discharge
|
Day of admission to day of discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Direct margin, $
Time Frame: Day of admission to day of discharge
|
Direct margin from total cost of hospitalization
|
Day of admission to day of discharge
|
Direct margin, modeled with backfill, $
Time Frame: Day of admission to day of discharge
|
Backfill uses a model that estimates the cost of patients who take the place of home hospital patients
|
Day of admission to day of discharge
|
Length of stay, days
Time Frame: Day of admission to day of discharge
|
Day of admission to day of discharge
|
|
Imaging, #
Time Frame: Day of admission to day of discharge
|
Day of admission to day of discharge
|
|
Lab Orders, #
Time Frame: Day of admission to day of discharge
|
Day of admission to day of discharge
|
|
Discharge Disposition
Time Frame: Day of discharge
|
Routine, skilled nursing facility, home health, other
|
Day of discharge
|
Readmission(s) after index hospitalization, y/n
Time Frame: Day of discharge to 30 days later
|
Dichotomous outcome
|
Day of discharge to 30 days later
|
Time to readmission after index hospitalization, days
Time Frame: Day of discharge to 30 days later
|
Survival curve (hazard analysis)
|
Day of discharge to 30 days later
|
Emergency Department (ED) observation stay(s) after index hospitalization, y/n
Time Frame: Day of discharge to 30 days later
|
Dichotomous outcome
|
Day of discharge to 30 days later
|
Time to ED observation stay(s) after index hospitalization, days
Time Frame: Day of discharge to 30 days later
|
Survival curve (hazard analysis)
|
Day of discharge to 30 days later
|
ED visit(s) after index hospitalization, y/n
Time Frame: Day of discharge to 30 days later
|
Dichotomous outcome
|
Day of discharge to 30 days later
|
Time to ED visit(s) after index hospitalization, days
Time Frame: Day of discharge to 30 days later
|
Survival curve (hazard analysis)
|
Day of discharge to 30 days later
|
Delirium, y/n
Time Frame: Day of admission to day of discharge
|
Day of admission to day of discharge
|
|
Transfer back to hospital, y/n
Time Frame: Day of admission to day of discharge
|
intervention arm only
|
Day of admission to day of discharge
|
Hours of sleep, #
Time Frame: Day of admission to day of discharge
|
Day of admission to day of discharge
|
|
Daily steps, #
Time Frame: Day of admission to day of discharge
|
Day of admission to day of discharge
|
|
EuroQol -5D-5L, composite score
Time Frame: At admission, at discharge, and at 30 days after discharge
|
At admission, at discharge, and at 30 days after discharge
|
|
Short Form 1
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
1-5 Likert scale
|
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
Activities of daily living, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
|
Instrumental activities of daily living, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
|
3-item Care Transition Measure, score
Time Frame: 30 days after discharge
|
30 days after discharge
|
|
Picker Experience Questionnaire, score
Time Frame: 30 days after discharge
|
30 days after discharge
|
|
Global satisfaction with care, score
Time Frame: 30 days after discharge
|
30 days after discharge
|
|
Qualitative interview
Time Frame: 30 days after discharge
|
30 days after discharge
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total cost of episode of care, $
Time Frame: Day of admission to 30 days after discharge
|
Exploratory; Subset of sample for which claims data is available
|
Day of admission to 30 days after discharge
|
Intraveneous medications, days
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Intraveneous fluids, days
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Intraveneous diuretics, days
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Intraveneous antibiotics, days
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Supplemental oxygen required, days
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Nebulizer treatment, days
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Medical Doctor sessions, # notes
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Consultant sessions, # notes
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Physical therapy/occupational therapy sessions, # notes
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Primary care provider follow-up within 14 days, y/n
Time Frame: Day of discharge to 14 days later
|
Exploratory
|
Day of discharge to 14 days later
|
Skilled nursing facility utilization, days
Time Frame: Day of discharge to 30 days later
|
Exploratory
|
Day of discharge to 30 days later
|
Home health utilization, days
Time Frame: Day of discharge to 30 days later
|
Exploratory
|
Day of discharge to 30 days later
|
Fall, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Diagnosis of hospital-acquired or post-discharge deep vein thrombosis or pulmonary embolism
Time Frame: Day of admission to 30 days after discharge
|
Exploratory
|
Day of admission to 30 days after discharge
|
Hospital-acquired pressure ulcer, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Thrombophlebitis at peripheral intravenous site, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Catheter-associated urinary tract infection, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Clostridium difficile infection, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Methicillin resistant staph aureus infection, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Mortality during admission, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Post-discharge mortality, y/n
Time Frame: Day of discharge to 30 days later
|
Exploratory
|
Day of discharge to 30 days later
|
New arrhythmia, y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Hypokalemia, y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Acute kidney injury, y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Mean Likert scale pain score, 0-10
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Pneumococcal vaccination if appropriate, y/n
Time Frame: Day of admission to day of discharge
|
Pneumonia patients only; Exploratory
|
Day of admission to day of discharge
|
Influenza vaccination if appropriate, y/n
Time Frame: Day of admission to day of discharge
|
Pneumonia patients only; Exploratory
|
Day of admission to day of discharge
|
Smoking cessation counseling if appropriate, y/n
Time Frame: Day of admission to day of discharge
|
Pneumonia and heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Evaluation of ejection fraction as assessed by echocardiogram or other appropriate study, scheduled or completed, if not done within 1 year; y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory; appropriate studies include cardiac magnetic resonance imaging, radionuclide ventriculography, single photon emission computed tomography myocardial perfusion imaging, or left ventriculography
|
Day of admission to day of discharge
|
Angiotensin converting enzyme inhibitor or angiotensin receptor blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Beta blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Aldosterone antagonist for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Lipid lowering for coronary artery disease, peripheral vascular disease, cerebrovascular accident, or diabetes, y/n
Time Frame: Day of admission to day of discharge
|
Heart failure patients only; Exploratory
|
Day of admission to day of discharge
|
Smoking status post-discharge
Time Frame: 30 days after day of discharge
|
Heart failure and pneumonia patients only; Exploratory; current/never/quit.
|
30 days after day of discharge
|
Use of inappropriate medications in the elderly, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory; using Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Beers criteria
|
Day of admission to day of discharge
|
Use of Foley catheter, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Use of restraints, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
>3 medications added to medication list, y/n
Time Frame: Day of discharge (compared with preadmission med list)
|
Exploratory
|
Day of discharge (compared with preadmission med list)
|
Patient health questionnaire-2, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
Exploratory
|
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
Patient-Reported Outcomes Measurement Information System Emotional Support Short Form 4a, score
Time Frame: 30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
Exploratory
|
30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge
|
Walk around ward/home, y/n
Time Frame: Day of discharge
|
Exploratory
|
Day of discharge
|
Get to (non-commode) bathroom, y/n
Time Frame: Day of discharge
|
Exploratory
|
Day of discharge
|
Walk 1 flight of stairs, y/n
Time Frame: Day of discharge
|
Exploratory
|
Day of discharge
|
Visit with friends/family, y/n
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Walk outside around my home, y/n
Time Frame: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Go shopping, y/n
Time Frame: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Time from admission decision to assessment by research assistant, minutes
Time Frame: Day of admission
|
Exploratory
|
Day of admission
|
Time from research assistant assessment to emergency department dismissal, minutes
Time Frame: Day of admission
|
Exploratory
|
Day of admission
|
Time from arrival home or to floor and medical doctor evaluation, minutes
Time Frame: Day of admission
|
Exploratory
|
Day of admission
|
Time from arrival home or to floor and registered nurse evaluation, minutes
Time Frame: Day of admission
|
Exploratory
|
Day of admission
|
Average Registered nurse to patient ratio
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Number of registered nurse visits, total
Time Frame: Day of admission to day of discharge
|
Exploratory
|
Day of admission to day of discharge
|
Number of "on call" medical doctor interactions (video or phone), total
Time Frame: Day of admission to day of discharge
|
Exploratory, intervention arm only
|
Day of admission to day of discharge
|
Number of "on call" medical doctor in-person visits, total
Time Frame: Day of admission to day of discharge
|
Exploratory, intervention arm only
|
Day of admission to day of discharge
|
Duration of 1st registered nurse visit, minutes
Time Frame: Day of admission
|
Exploratory, intervention arm only
|
Day of admission
|
Average Duration of subsequent registered nurse visit, minutes
Time Frame: Day of admission to day of discharge
|
Exploratory, intervention arm only
|
Day of admission to day of discharge
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Cryer L, Shannon SB, Van Amsterdam M, Leff B. Costs for 'hospital at home' patients were 19 percent lower, with equal or better outcomes compared to similar inpatients. Health Aff (Millwood). 2012 Jun;31(6):1237-43. doi: 10.1377/hlthaff.2011.1132.
- Leff B, Burton L, Mader SL, Naughton B, Burl J, Inouye SK, Greenough WB 3rd, Guido S, Langston C, Frick KD, Steinwachs D, Burton JR. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med. 2005 Dec 6;143(11):798-808. doi: 10.7326/0003-4819-143-11-200512060-00008.
- Hung WW, Ross JS, Farber J, Siu AL. Evaluation of the Mobile Acute Care of the Elderly (MACE) service. JAMA Intern Med. 2013 Jun 10;173(11):990-6. doi: 10.1001/jamainternmed.2013.478.
- Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009 Apr;5(4):210-20. doi: 10.1038/nrneurol.2009.24.
- Counsell SR, Holder CM, Liebenauer LL, Palmer RM, Fortinsky RH, Kresevic DM, Quinn LM, Allen KR, Covinsky KE, Landefeld CS. Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital. J Am Geriatr Soc. 2000 Dec;48(12):1572-81. doi: 10.1111/j.1532-5415.2000.tb03866.x.
- Montalto M. The 500-bed hospital that isn't there: the Victorian Department of Health review of the Hospital in the Home program. Med J Aust. 2010 Nov 15;193(10):598-601. doi: 10.5694/j.1326-5377.2010.tb04070.x.
- Levine DM, Ouchi K, Blanchfield B, Diamond K, Licurse A, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: a Pilot Randomized Controlled Trial. J Gen Intern Med. 2018 May;33(5):729-736. doi: 10.1007/s11606-018-4307-z. Epub 2018 Feb 6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016P001337
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
Clinical Trials on Inpatient Hospitalization
-
Brigham and Women's HospitalVital Connect; Smiths MedicalCompletedHeart Failure | Chronic Kidney Diseases | Asthma | Infection | COPD | Gout Flare | Hypertensive Urgency | Anticoagulants; Increased | Atrial Fibrillation RapidUnited States
-
Rabin Medical CenterUnknown
-
Providence Health & ServicesPatient-Centered Outcomes Research Institute; Oregon Health and Science University and other collaboratorsUnknown
-
Hospital Clinic of BarcelonaCompletedUnrecognized ConditionSpain
-
University of Alabama at BirminghamUniversity of Maryland; University Teaching HospitalRecruitingHIV/AIDS | Tuberculosis | Cryptococcosis | Hospitalization | HIV Testing | Transitions of CareZambia
-
University of L'AquilaGlaxoSmithKlineRecruitingHerpes Zoster | Comorbidities and Coexisting ConditionsItaly
-
Fudan UniversityRecruitingNeoplasms | Surgery | Drug Therapy | Radiotherapy | SurvivalChina
-
Washington University School of MedicineRecruiting
-
Peking University Third HospitalPeking UniversityRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting